Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
INDUSTRY
×
HER2-mutant Non-Small Cell Lung Cancer
×
Clear all
Filters
3
NCT05246514
2025-08-28
DL-05
AstraZeneca
Phase 2
Active not recruiting
72 enrolled
16 charts